# Fimasartan Achieving SBP Target (FAST) Study

Study · id `cardio:ct-nct02495324` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02495324](<https://clinicaltrials.gov/study/NCT02495324>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02495324

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 369 participants.

## Technical summary

Registry record NCT02495324. Randomized; quadruple masking; primary purpose treatment. Start 2015-06 (actual); primary completion 2017-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 369 participants (enrolled count; ClinicalTrials.gov record NCT02495324, source copy `cardio:ctgov-nct02495324-2017-07-05`, retrieved 2026-10-26)
- Started: 2015-06 (actual) (ClinicalTrials.gov record NCT02495324, source copy `cardio:ctgov-nct02495324-2017-07-05`, retrieved 2026-10-26)
- Primary completion: 2017-05 (actual) (ClinicalTrials.gov record NCT02495324, source copy `cardio:ctgov-nct02495324-2017-07-05`, retrieved 2026-10-26)
- Completion: 2017-05 (actual) (ClinicalTrials.gov record NCT02495324, source copy `cardio:ctgov-nct02495324-2017-07-05`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02495324, source copy `cardio:ctgov-nct02495324-2017-07-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02495324-2017-07-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Fimasartan Achieving SBP Target (FAST) Study
- Acronym: FAST
- Condition: Essential,Hypertension
- Intervention (Drug): Placebo
- Intervention (Drug): Fimasartan
- Intervention (Drug): Valsartan
- Intervention (Drug): Olmesartan medoxomil
- Lead sponsor: Boryung Pharmaceutical Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Valsartan (`cardio:valsartan`)
- Registry intervention name matches this record: Olmesartan (`cardio:olmesartan`)
- Registry lists this organization as the lead sponsor: Boryung Pharmaceutical Co., Ltd (`cardio:org-boryung-pharmaceutical-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study) (`cardio:pubmed-32158190`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6e63f19ecad9b8c60b6d17cb9d5673130928e18cc66bb022ca1eebeb4ce1419c
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
